of values for normal children of this age is 0-7-1-1 which compares with the values given by Phillips and Vassilopoulou-Sellin. 2 Our observations of somatomedin activity in this condition, although conflicting with those of Robinow and Shafer, are supported by those of Ashton and Aynsley-Green. 3 The difference between our findings and those of Professor Robinow could be due to the difference in the assays used. Both my results and those of Ashton were obtained with bioassays to determine somatomedin activity, while Robinow and Schafer used a radioimmunoassay. Direct comparison of somatomedin activity between the two types of assay used is difficult to make, particularly as the normal range quoted by Robinow and Schafer (0.4-2.0 U/ml) would cover the complete range of somatomedin activity (from hypopituitarism to acromegaly) in most bioassay systems.
No results are presented by Robinow and Shafer for insulin levels; however, the hypoglycaemia in their patients must presumably have been due to hyperinsulinaemia. These results are therefore interesting as, to my knowledge, no other such association between high insulin and low somatomedin has yet been demonstrated. Similarly, it is also difficult to reconcile the gigantism of the Beckwith-Wiedemann syndrome with low somatomedin levels, and I know of no other reported cases of such excessive growth in the absence of somatomedins.
If the difference in somatomedin levels is due to the different assays used, then either there is a factor which interferes in the radioimmunoassay, or the somatomedin-C radioimmunoassay used fails to cross-react with any of the other recognised somatomedins, or there is, in patients with Beckwith-Wiedemann syndrome, a previously unrecognised serum growth factor which is capable of stimulating growth in vivo and cartilage growth in vitro. This may be a modified (non-immunoreactive but biologically active) somatomedin molecule.
The conflict in these results should be investigated. Birth factors such as young maternal age and admission to a special care unit have been shown to be important, but factors after birth have been difficult to assess. We have studied the medical records of 80 children on the South Glamorgan Area Review Committee Child Abuse Register, particularly in respect of admissions to hospital for poisoning before the episode of abuse. All of the children had been either physically injured or had suffered clearcut neglect before age 5. The records of 80 control children, whose names were obtained from the Cardiff Birth Survey and matched for age and sex, were also studied.
Ten of the 80 abused children had poisoning episodes before their placement on the register for child abuse. Three of them had taken salicylates, three benzodiazapines, two domestic bleach, one sherry, and the other unknown tablets. Two of the control children had been admitted for poisoning episodes, one after ingesting perfume and the other after paediatric metoclopramide (Maxolon). The difference between the cases (10) and controls (2) is significant, P<0.05 X2 4-41.
Although nonaccidental poisoning is recognised as a type of child abuse,2 we believe that the episodes we describe were accidental, indicating family stress which has been shown to be a factor in child poisoning3 and other accidents.4 These figures are a further indication that child poisoning should be considered as an important symptom of family problems and should alert all those concerned in the primary care of children. 
